Time to complete wound healing in HIV-positive and HIV-negative men following medical male circumcision in Kisumu, Kenya: a prospective cohort study
- PMID: 23613918
- PMCID: PMC3626701
- DOI: 10.1371/journal.pone.0061725
Time to complete wound healing in HIV-positive and HIV-negative men following medical male circumcision in Kisumu, Kenya: a prospective cohort study
Abstract
Background: While voluntary medical male circumcision (VMMC) has been shown to be protective against HIV-acquisition, the procedure may place men and their partners at risk of HIV infection in the period following circumcision if sex is resumed before the wound is healed. This prospective cohort study evaluates post-circumcision wound healing to determine whether the 42-day post-circumcision abstinence period, recommended by the World Health Organization and adopted by VMMC programs, is optimal.
Methods and findings: Men were circumcised by forceps-guided method and their post-circumcision wounds examined weekly for seven weeks and at 12 weeks. Time to complete healing was recorded in completed weeks since circumcision, and its associations with baseline covariates were assessed by Kaplan-Meier methods and Cox Proportional Hazard Models. A total of 215 HIV-negative and 108 HIV-positive men aged 18-35 years (median 26, IQR 23-30) were enrolled. 97.1% of scheduled follow-up visits were completed. At week 4, 59.3% of HIV-positive men and 70.4% of age-matched HIV-negative men were healed. At week 6, these percentages rose to 93.4% in HIV-positive men and 92.6% in age-matched HIV-negative men. There was no difference in the hazard of healing between 108 HIV-positive and 108 age-matched HIV-negative men (HR 0.91 95% CI 0.70-1.20). Early post-operative infection was associated with delayed healing in both HIV-positive and HIV-negative men (HR 0.48 95% CI 0.23-1.00).
Conclusions: Our results indicate that the WHO recommendation for 42-days post-circumcision sexual abstinence should be maintained for both HIV-positive and HIV-negative men. It is important to stress condom use upon resumption of sex in all men undergoing circumcision.
Conflict of interest statement
Figures
Similar articles
-
Changes in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya.J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):511-7. doi: 10.1097/QAI.0b013e3182a7ef05. J Acquir Immune Defic Syndr. 2013. PMID: 23933768 Free PMC article.
-
Male circumcision wound healing in human immunodeficiency virus (HIV)-negative and HIV-positive men in Rakai, Uganda.BJU Int. 2014 Jan;113(1):127-32. doi: 10.1111/bju.12406. Epub 2013 Nov 27. BJU Int. 2014. PMID: 24053645
-
Factors associated with resumption of sex before complete wound healing in circumcised HIV-positive and HIV-negative men in Kisumu, Kenya.J Acquir Immune Defic Syndr. 2013 Apr 1;62(4):465-70. doi: 10.1097/QAI.0b013e3182800710. J Acquir Immune Defic Syndr. 2013. PMID: 23242159 Free PMC article.
-
Voluntary medical male circumcision for HIV prevention and early resumption of sexual activity: a literature review.AIDS Care. 2015;27(8):986-9. doi: 10.1080/09540121.2015.1017797. Epub 2015 Mar 4. AIDS Care. 2015. PMID: 25738780 Review.
-
Risk Compensation in Voluntary Medical Male Circumcision Programs.Curr HIV/AIDS Rep. 2022 Dec;19(6):516-521. doi: 10.1007/s11904-022-00635-9. Epub 2022 Nov 9. Curr HIV/AIDS Rep. 2022. PMID: 36350470 Review.
Cited by
-
Effect of text messaging to deter early resumption of sexual activity after male circumcision for HIV prevention: a randomized controlled trial.J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):e50-7. doi: 10.1097/QAI.0b013e3182a0a050. J Acquir Immune Defic Syndr. 2014. PMID: 23846561 Free PMC article. Clinical Trial.
-
Changes in plasma viral load and penile viral shedding after circumcision among HIV-positive men in Kisumu, Kenya.J Acquir Immune Defic Syndr. 2013 Dec 15;64(5):511-7. doi: 10.1097/QAI.0b013e3182a7ef05. J Acquir Immune Defic Syndr. 2013. PMID: 23933768 Free PMC article.
-
Factors Associated With Delayed Healing in a Study of the PrePex Device for Adult Male Circumcision in Kenya.J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1(Suppl 1):S24-9. doi: 10.1097/QAI.0000000000000736. J Acquir Immune Defic Syndr. 2016. PMID: 27331586 Free PMC article.
-
Safety and efficacy of the PrePex device in HIV-positive men: A single-arm study in Zimbabwe.PLoS One. 2017 Dec 8;12(12):e0189146. doi: 10.1371/journal.pone.0189146. eCollection 2017. PLoS One. 2017. PMID: 29220392 Free PMC article.
-
Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision: Safety, Effectiveness, and Acceptability of Using 7 Versus 14 Device Sizes.J Acquir Immune Defic Syndr. 2016 Jun 1;72 Suppl 1(Suppl 1):S30-5. doi: 10.1097/QAI.0000000000001015. J Acquir Immune Defic Syndr. 2016. PMID: 27331587 Free PMC article. Clinical Trial.
References
-
- Bailey RC, Moses S, Parker CB, Agot K, Maclean I, et al. (2007) Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 369: 643–656. - PubMed
-
- Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, et al. (2007) Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 369: 657–666. - PubMed
-
- World Health Organization Joint United Nations Program on HIV/AIDS (2007) New Data on Male Circumcision and HIV Prevention: Policy and Programme Implications. Montreux: World Health Organization. Available: http://data.unaids.org/pub/Report/2007/mc_recommendations_en.pdf. Accessed 2013 Feb 7.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical